ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
GPCR News
Learn more about Neurocrine Biosciences with their new video
Verily links up with Sosei Heptares for GPCR drug discovery
ShouTi Pharma has a brand new website
Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
Drug Discovery Picks Up the Pace, Stays on Target
Learn more about Neurocrine Biosciences with their new video
A role for BET proteins in regulating basal, dopamine-induced and cAMP/PKA-dependent ...
Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...
Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E,
Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
G-protein-coupled receptors as therapeutic targets for glioblastoma
Precise druggability of the PTH type 1 receptor
A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
Phospholipid Scrambling by G Protein-Coupled Receptors